Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis

Condition:   Plaque Psoriasis Intervention:   Drug: ARQ-151- cream 0.3% Sponsor:   Arcutis Biotherapeutics, Inc. Not yet recruiting

Source: ClinicalTrials.gov - February 20, 2020 Category: Research Source Type: clinical trials